BMRN
BioMarin Pharmaceutical Inc.
November 4, 2026 · pre-market open
- Rarity
- 1.64
- Peak move
- +5.82%
- Float cap
- $10.6B
BioMarin Pharmaceutical Inc. is a global rare disease biotechnology company that develops and commercializes therapies for genetically defined conditions. Its commercial products include VOXZOGO for achondroplasia, enzyme replacement therapies for mucopolysaccharidoses, and PALYNZIQ for phenylketonuria. The company serves patients with rare genetic diseases worldwide.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNot searched yet.A blank here does not mean there was no cause.